SEC Form 4 · accession 0001140361-16-051878
Raptor Pharmaceutical Corp · RPTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Happel
Officer — Chief Commerical Officer
Period of report
Feb 9, 2016
Accepted (ET)
Feb 11, 2016 · 7:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 9, 2016 | A | 25,017 | $0.00 | A | 30,246 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F3 | $3.74 | Feb 9, 2016 | A | 93,784 | A | — | Feb 9, 2026 | Common Stock | 93,784 | 93,784 | D |
Explanation of responses
- F1Restricted Stock Units ("RSUs"). The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU, subject to continued service.
- F2One-fourth of the total RSUs vest annually, beginning on the first anniversary of the grant date.
- F3The options have a four year vesting schedule, vesting 1/48th per month following the grant date.